SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Concord Biotech

BSE: 543960 22 Aug 2025
Healthcare
₹ 1771.8
Concord Biotech Limited specializes in Pharmaceuticals within the Healthcare sector.

Concord Biotech - Share Price & Details

Market Cap
₹18,310
High /Low
2,664 / 1,345
Stock P/E
51.4
Book Value
₹173.0
Dividend Yield
0.61
ROCE
28.2
ROE
₹21.3
Face Value
1.0
PEG Ratio
1.87
EVEBITDA
₹34.4
Debt
2.97
CMP / FCF
133.0
Debt to equity
₹0.0
NP Ann
372
High price all time
2,664
Piotroski score
₹5.0
Graham Number
364.0
No. Eq. Shares
10.5
Net CF
₹-14.2
Net profit
356
Price to book value
10.1
Interest Coverage
₹1,317
Low price all time
900.0
Industry PE
32.8
Reserves
₹1,802
Free Cash Flow
₹134

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
Concord Biotech Limited2176.65425.652039.884.0718,31051.4
NEULAND LABORATORIES LTD.3006.09137.082927.5310.6817744135.0
530019602.058.0595.00.261725335.5

Peer Comparison Chart


About Concord Biotech

Concord Biotech Limited, with Security Code 543960, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Stocks to buy in 2025 for long term: Concord Biotech, Genus Power among 5 stocks that could give 17-38% return

(13 Aug 2025)
Brokerages have turned positive on a range of stocks across sectors, projecting double-digit upside potential based on strong growth...
Read more →

Concord Biotech shares: Jhunjhunwala takes a Rs 300 cr hit in 2 mins as stock tanks 8%

(11 Aug 2025)
Concord Biotech shares: Over Rs 300 crore were wiped out from the portfolio of legendary investor Jhunjhunwala's portfolio as the stock...
Read more →

Concord Biotech Releases Q1 2025 Financial Results

(11 Aug 2025)
Concord Biotech Ltd. ( ($IN:CONCORDBIO) ) has issued an update. Concord Biotech Ltd. has released an investor presentation detailing its...
Read more →

Concord Biotech Reports Decline in Key Financial Metrics for August 2025 Results

(09 Aug 2025)
Concord Biotech has released its financial results for the quarter ending June 2025, revealing a decline in key metrics. Net sales, profit before tax,...
Read more →

Concord Biotech standalone net profit declines 26.91% in the June 2025 quarter

(09 Aug 2025)
Net profit of Concord Biotech declined 26.91% to Rs 42.57 crore in the quarter ended June 2025 as against Rs 58.24 crore during the previous quarter ended...
Read more →

Concord Biotech Limited (543960)’s Trend in 2025 - Explosive portfolio gains

(24 Jul 2025)
Concord Biotech Limited (543960)'s Trend in 2025 ✌️【Trading Ideas】✌️ With a focus on accuracy and timing, we've built a system that helps...
Read more →

Company Updates